CAS 2607139-80-8

4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)-

Description:

4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)- is a synthetic organic compound characterized by its complex molecular structure, which includes an imidazolidine ring and various functional groups such as amide and pyridine. The presence of halogen atoms, specifically chlorine and fluorine, contributes to its unique chemical properties, potentially enhancing its biological activity and lipophilicity. This compound is likely to exhibit specific interactions with biological targets, making it of interest in pharmaceutical research. Its stereochemistry, indicated by the (4S) designation, suggests that it has a specific spatial arrangement that may influence its efficacy and safety profile. The compound's solubility, stability, and reactivity are influenced by its functional groups and overall structure, which are critical for its application in medicinal chemistry. As with many synthetic compounds, understanding its characteristics requires thorough investigation through experimental studies and computational modeling to elucidate its behavior in biological systems.

Formula: C₁₈H₁₄ClF₅N₄O₂

Synonyms:

• 4-Imidazolidinecarboxamide, N-(3-chloro-2,4-difluorophenyl)-N-methyl-3-[6-methyl-4-(trifluoromethyl)-2-pyridinyl]-2-oxo-, (4S)-

PolQi1

CAS: 2607139-80-8

PolQi1

Purity: ≥98%

Molecular weight: 448.77g/mol

Ref: 54-BUP21457

PolQi1

CAS: 2607139-80-8

PolQi1 is a highly efficient and selective Polϴ (DNA polymerase theta) inhibitor with an IC50 of 2 nM, showing potential for cancer therapy.

Formula: C₁₈H₁₄ClF₅N₄O₂

Purity: 98.97%

Color and Shape: Solid

Molecular weight: 448.77

Ref: TM-T89335